MS4A1 and B-cell chronic lymphocytic leukemia: Consistent with our results, prior work has also demonstrated that cellular fragility markers such as smudge cells correlate with disease outcomes in CLL [8], further supporting the potential of soluble CD20 as a prognostic biomarker.